These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22371070)

  • 1. Common MUTYH mutations and colorectal cancer risk in multiethnic populations.
    Lejbkowicz F; Cohen I; Barnett-Griness O; Pinchev M; Poynter J; Gruber SB; Rennert G
    Fam Cancer; 2012 Sep; 11(3):329-35. PubMed ID: 22371070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased risk for colorectal adenomas and cancer in mono-allelic MUTYH mutation carriers: results from a cohort of North-African Jews.
    Rosner G; Bercovich D; Daniel YE; Strul H; Fliss-Isakov N; Ben-Yehoiada M; Santo E; Halpern Z; Kariv R
    Fam Cancer; 2015 Sep; 14(3):427-36. PubMed ID: 25822476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MutYH mutation carriers have increased breast cancer risk.
    Rennert G; Lejbkowicz F; Cohen I; Pinchev M; Rennert HS; Barnett-Griness O
    Cancer; 2012 Apr; 118(8):1989-93. PubMed ID: 21952991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MUTYH hotspot mutations in unselected colonoscopy patients.
    Casper M; Plotz G; Juengling B; Zeuzem S; Lammert F; Raedle J
    Colorectal Dis; 2012 May; 14(5):e238-44. PubMed ID: 22469480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of monoallelic MUTYH mutation among Egyptian patients with colorectal cancer.
    Elsaid A; Elshazli R; El-Tarapely F; Darwish H; Abdel-Malak C
    Fam Cancer; 2017 Jan; 16(1):83-90. PubMed ID: 27631816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of the common germline MUTYH mutations p.G396D and p.Y179C in patients diagnosed with colorectal cancer in Southern Brazil.
    Pitroski CE; Cossio SL; Koehler-Santos P; Graudenz M; Prolla JC; Ashton-Prolla P
    Int J Colorectal Dis; 2011 Jul; 26(7):841-6. PubMed ID: 21424714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simplifying the detection of MUTYH mutations by high resolution melting analysis.
    López-Villar I; Ayala R; Wesselink J; Morillas JD; López E; Marín JC; Díaz-Tasende J; González S; Robles L; Martínez-López J
    BMC Cancer; 2010 Aug; 10():408. PubMed ID: 20687945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants.
    Theodoratou E; Campbell H; Tenesa A; Houlston R; Webb E; Lubbe S; Broderick P; Gallinger S; Croitoru EM; Jenkins MA; Win AK; Cleary SP; Koessler T; Pharoah PD; Küry S; Bézieau S; Buecher B; Ellis NA; Peterlongo P; Offit K; Aaltonen LA; Enholm S; Lindblom A; Zhou XL; Tomlinson IP; Moreno V; Blanco I; Capellà G; Barnetson R; Porteous ME; Dunlop MG; Farrington SM
    Br J Cancer; 2010 Dec; 103(12):1875-84. PubMed ID: 21063410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing germline APC and MUTYH variants in Ashkenazi Jews compared to other individuals.
    Ukaegbu C; Levi Z; Fehlmann TD; Uno H; Chittenden A; Inra JA; Grover S; Kastrinos F; Syngal S; Yurgelun MB
    Fam Cancer; 2021 Apr; 20(2):111-116. PubMed ID: 32743790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MUTYH hotspot mutations p.G396D and p.Y179C do not cause substantial genetic susceptibility to biliary cancer.
    Casper M; Acalovschi M; Lammert F; Zimmer V
    Fam Cancer; 2014 Jun; 13(2):243-7. PubMed ID: 24420788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of MUTYH genotypes and colorectal phenotypes in patients With MUTYH-associated polyposis.
    Nielsen M; Joerink-van de Beld MC; Jones N; Vogt S; Tops CM; Vasen HF; Sampson JR; Aretz S; Hes FJ
    Gastroenterology; 2009 Feb; 136(2):471-6. PubMed ID: 19032956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of bi-allelic germline MUTYH mutations to early-onset and familial colorectal cancer and to low number of adenomatous polyps: case-series and literature review.
    Knopperts AP; Nielsen M; Niessen RC; Tops CM; Jorritsma B; Varkevisser J; Wijnen J; Siezen CL; Heine-Bröring RC; van Kranen HJ; Vos YJ; Westers H; Kampman E; Sijmons RH; Hes FJ
    Fam Cancer; 2013 Mar; 12(1):43-50. PubMed ID: 23007840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas.
    Grover S; Kastrinos F; Steyerberg EW; Cook EF; Dewanwala A; Burbidge LA; Wenstrup RJ; Syngal S
    JAMA; 2012 Aug; 308(5):485-492. PubMed ID: 22851115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of APC and MUTYH germ-line mutations in Russian patients with colorectal malignancies.
    Yanus GA; Akhapkina TA; Ivantsov AO; Preobrazhenskaya EV; Aleksakhina SN; Bizin IV; Sokolenko AP; Mitiushkina NV; Kuligina ES; Suspitsin EN; Venina AR; Holmatov MM; Zaitseva OA; Yatsuk OS; Pashkov DV; Belyaev AM; Togo AV; Imyanitov EN; Iyevleva AG
    Clin Genet; 2018 May; 93(5):1015-1021. PubMed ID: 29406563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer.
    Win AK; Dowty JG; Cleary SP; Kim H; Buchanan DD; Young JP; Clendenning M; Rosty C; MacInnis RJ; Giles GG; Boussioutas A; Macrae FA; Parry S; Goldblatt J; Baron JA; Burnett T; Le Marchand L; Newcomb PA; Haile RW; Hopper JL; Cotterchio M; Gallinger S; Lindor NM; Tucker KM; Winship IM; Jenkins MA
    Gastroenterology; 2014 May; 146(5):1208-11.e1-5. PubMed ID: 24444654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The I1307K APC polymorphism: prevalence in non-Ashkenazi Jews and evidence for a founder effect.
    Shtoyerman-Chen R; Friedman E; Figer A; Carmel M; Patael Y; Rath P; Fidder HH; Bar-Meir S; Theodor L
    Genet Test; 2001; 5(2):141-6. PubMed ID: 11551102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of BRCA1 and BRCA2 mutations in Ashkenazi colorectal cancer patients: preliminary study.
    Drucker L; Stackievitz R; Shpitz B; Yarkoni S
    Anticancer Res; 2000; 20(1B):559-61. PubMed ID: 10769725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population.
    Foulkes WD; Thiffault I; Gruber SB; Horwitz M; Hamel N; Lee C; Shia J; Markowitz A; Figer A; Friedman E; Farber D; Greenwood CM; Bonner JD; Nafa K; Walsh T; Marcus V; Tomsho L; Gebert J; Macrae FA; Gaff CL; Paillerets BB; Gregersen PK; Weitzel JN; Gordon PH; MacNamara E; King MC; Hampel H; De La Chapelle A; Boyd J; Offit K; Rennert G; Chong G; Ellis NA
    Am J Hum Genet; 2002 Dec; 71(6):1395-412. PubMed ID: 12454801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoallelic MUTYH carrier status is not associated with increased breast cancer risk in a multigene panel cohort.
    Fulk K; LaDuca H; Black MH; Qian D; Tian Y; Yussuf A; Espenschied C; Jasperson K
    Fam Cancer; 2019 Apr; 18(2):197-201. PubMed ID: 30582135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of the c.1227_1228dup (p.Glu410GlyfsX43) mutation in Tunisian families affected with MUTYH-associated-polyposis.
    Abdelmaksoud-Dammak R; Miladi-Abdennadher I; Amouri A; Tahri N; Ayadi L; Khabir A; Frikha F; Gargouri A; Mokdad-Gargouri R
    Fam Cancer; 2012 Sep; 11(3):503-8. PubMed ID: 22744763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.